医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Dexlevo’s GOURI Symposium and Brand Event at IMCAS 2023

2023年02月03日 PM05:15
このエントリーをはてなブックマークに追加


 

SEOUL, South Korea

Dexlevo, a company specializing in aesthetic medical devices, successfully held a symposium dedicated to its exclusive product, ‘GOURI’, at the IMCAS World Congress 2023 in Paris. IMCAS (International Master Course on Aging Science), held from Jan 26th to Jan 28th in Paris, France, is one of the world’s three major aesthetics anti-aging societies.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230202005935/en/

GOURI Booth at IMCAS Paris 2023 (Photo: Business Wire)

GOURI Booth at IMCAS Paris 2023 (Photo: Business Wire)

Over 200 doctors and companies who visited Dexlevo’s booth showed great interest in GOURI – a unique injectable that provides a fundamental solution to anti-aging.

GOURI symposium titled “Universal Anti-Aging Treatment” was conducted by an Australian dermatologist Dr. Paul Han, who apart from giving a lecture also demonstrated a new GOURI treatment protocol which lately has gained increasing popularity among doctors who use GOURI. Dr. Paul commented, “While keeping the results as great as we had with the previous protocol, the new one dramatically improves the patient’s experience and reduces the patient’s fear of treatment due to pain.”

An exclusive Dexlevo’s brand event called Gorgeous GOURI Night was held on the evening of Jan 26th. It was a customized event where GOURI doctors and distributors worldwide could share their experience and knowledge about the product. After the “Gorgeous GOURI Experience” session, where doctors freely presented their cases and treatment experiences, guests got a chance to experience Korean traditional music – gugak – and clothing – hanbok.

Dexlevo’s representative said, “Through Gorgeous GOURI Night, an exclusive event dedicated solely to GOURI, we aimed to enhance product understanding and promote brand awareness. It was an opportunity for doctors to expand their network” and added, “We plan to keep demonstrating the excellence of GOURI through various marketing activities, such as holding brand events and participating in international anti-aging conferences.”

Dexlevo’s GOURI is the world’s first liquefied polycaprolatone (PCL) collagen stimulator that naturally spreads throughout the face after injection, including the area around the eyes, to induce collagen production.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230202005935/en/

CONTACT

DEXLEVO

Lia Ko

lia.Ko@dexlevo.com

+821051022559

同じカテゴリーの記事 

  • 卫材启用Medidata Clinical Data Studio推进临床试验效率和患者体验的革新
  • Fujirebio推出研究专用全自动Lumipulse®G GFAP检测试剂盒并进一步强化该公司的神经病学产品阵容
  • Fujirebio Launches the Fully Automated Lumipulse® G GFAP Assay for Research Use Only and Further Strengthens its Neuro Test Menu
  • Pearl、歯科AIで史上最大5,800万ドルの資金調達ラウンドを実施
  • FIGS Announces Date of Second Quarter 2024 Earnings Release, Conference Call and Webcast